Fetal Hypoglycemia Induced by Placental SLC2A3 -RNA Interference Alters Fetal Pancreas Development and Transcriptome at Mid-Gestation

• Published in: International journal of molecular sciences Vol. 25; no. 9; p. 4780
• Main Authors: Kennedy, Victoria C, Lynch, Cameron S, Tanner, Amelia R, Winger, Quinton A, Gad, Ahmed, Rozance, Paul J, Anthony, Russell V
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-05-2024
• Subjects: Animals; Cell growth; Female; Fetal Development - genetics; Fetus - metabolism; Fetuses; Gene Expression Profiling; Gene Expression Regulation, Developmental; Genes; Glucagon; Glucose; Glucose - metabolism; Glucose Transporter Type 3 - genetics; Glucose Transporter Type 3 - metabolism; glucose uptake; Homeostasis; Hypoglycemia; Hypoglycemia - genetics; Hypoglycemia - metabolism; Insulin; Metabolism; Pancreas; Pancreas - embryology; Pancreas - metabolism; placenta; Placenta - metabolism; Pregnancy; RNA Interference; Sheep; SLC2A3; Transcription factors; Transcriptome; transcriptomics; transcriptomics; glucagon; placenta; SLC2A3; glucose uptake; insulin
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25094780

Glucose, the primary energy substrate for fetal oxidative processes and growth, is transferred from maternal to fetal circulation down a concentration gradient by placental facilitative glucose transporters. In sheep, SLC2A1 and SLC2A3 are the primary transporters available in the placental epithelium, with SLC2A3 located on the maternal-facing apical trophoblast membrane and SLC2A1 located on the fetal-facing basolateral trophoblast membrane. We have previously reported that impaired placental SLC2A3 glucose transport resulted in smaller, hypoglycemic fetuses with reduced umbilical artery insulin and glucagon concentrations, in addition to diminished pancreas weights. These findings led us to subject RNA derived from
-RNAi (RNA interference) and NTS-RNAi (non-targeting sequence) fetal pancreases to qPCR followed by transcriptomic analysis. We identified a total of 771 differentially expressed genes (DEGs). Upregulated pathways were associated with fat digestion and absorption, particularly fatty acid transport, lipid metabolism, and cholesterol biosynthesis, suggesting a potential switch in energetic substrates due to hypoglycemia. Pathways related to molecular transport and cell signaling in addition to pathways influencing growth and metabolism of the developing pancreas were also impacted. A few genes directly related to gluconeogenesis were also differentially expressed. Our results suggest that fetal hypoglycemia during the first half of gestation impacts fetal pancreas development and function that is not limited to β cell activity.